UNDER NEW MANAGEMENT
PLEASE CLICK ON THE IMAGE BELOW !
We have been supplying South Africans peptides since 2010 are the the oldest and most reliable suppliers of these products.
Labratory use only
We ship anywhere in South Africa counter to counter.
Payment cash in advance via ABSA cash send or Post office.
Request a quote : firstname.lastname@example.org
Please do not request directions for use. We offer information on the peptides only and due to the large number of requests for usage information, we are no longer able to supply these details. Please check other web resources for direction of use for each peptide.
Miracle or Myth - Peptides and Myostatin Inhibitors
A potential miracle cure for muscle diseases such as muscular dystrophy is now available. Amazing "never before seen" results achieved by bodybuilders all over the world and test results show the product has mind blowing results when used as treatment for various muscle related diseases and heart conditions, as well as for Body builders and people looking to be body beautiful !
Science-daily (Mar. 13, 2008) - "Myostatin, a protein that blocks muscle growth, has shown promising results as a potential therapeutic target for treating muscular dystrophy in animal studies, where its inhibition led to increased muscle mass and strength. A new study, the first to evaluate a myostatin inhibitor in human patients, assessed its safety in adults with muscular dystrophy and found that it was well-tolerated."
Gene Therapy (Doping) allows for muscle growth with the use of Myostatin inhibitors such as Follistatin and Myto-335
From movie stars to athletes to the average high school teen, the desire to have a muscular body has become ever more important. Outside of popular culture, several neuromuscular disorders result in severe weakness of the quadriceps. Researchers at Nationwide Children's Hospital are developing a gene delivery strategy that produces follistatin. Follistatin is a naturally occurring protein that inhibits myostatin, a growth factor expressed specifically in skeletal muscle. The result of this inhibition is that directly long-term gene expression with muscle enhancing effects.
Brian Kaspar, PhD, principal investigator in the Center for Gene Therapy of The Research Institute at Nationwide Children's Hospital said that "studies indicate that this relatively non-invasive approach could have long-term effects, involve few risks and could potentially be effective in various types of degenerative muscle disorders including multiple forms of muscular dystrophy." Their research has proven successful in non-human primates. The muscles size was shown to increase by 15%, and muscle strength was shown to increase by 78%. The effect lasted for the 15 month study with no negative health effects. The research could also highlight methods of weight control and reduction of obesity.
This drug would be able to tap into an extensive market with an estimated 7 million people who take steroids to boost their muscles (in spite of the health risks), while also providing a solution to a wide range of neuromuscular diseases and weight control. Thus, the research has the potential, like many other gene targeted drugs, to remove a large burden from the current healthcare infrastructure. Shifting emphasis towards preventive solutions, and avoiding high cost surgical and invasive options.